Multiple once-daily subcutaneous doses of pasireotide were well tolerated in healthy male volunteers: a randomized, double-blind, placebo-controlled, cross-over, Phase I study

✍ Scribed by Beglinger, Christoph; Hu, Ke; Wang, Ying; Bouillaud, Emmanuel; Darstein, Christelle; Wang, Yanfeng; Mohideen, Pharis

• Book ID: 118820981
• Publisher: Springer
• Year: 2012
• Tongue: English
• Weight: 477 KB
• Volume: 42
• Category: Article
• ISSN: 0969-711X
• DOI: 10.1007/s12020-012-9668-1